Literature DB >> 12372136

The involvement of matrix metalloproteinases in basement membrane injury in a murine model of acute allergic airway inflammation.

K Kumagai1, I Ohno, K Imai, J Nawata, K Hayashi, S Okada, H Senoo, T Hattori, K Shirato.   

Abstract

BACKGROUND: Airway remodelling in asthma such as subepithelial fibrosis is thought to be the repair process that follows the continuing injury as of chronic airway inflammation. However, how acute allergic inflammation causes tissue injury in the epithelial basement membrane in asthmatic airways remains unclear. Matrix metalloproteinases (MMPs) capable of degrading almost all of the extracellular matrix components have been demonstrated to be involved in cell migration through the basement membrane in vivo and in vitro.
OBJECTIVE: We investigated the alterations of matrix construction and the role of MMPs in matrix degradation in the subepithelium during acute allergic airway inflammation.
METHODS: Airway inflammation, the ultrastructure of the subepithelium and injury of types III and IV collagen in tracheal tissues from ovalbumin (OVA)-sensitized mice after OVA inhalation with or without the administration of tissue inhibitor of metalloproteinase-2 (TIMP-2) and dexamethasone were evaluated by cell counting in bronchoalveolar lavage (BAL) fluids, electron microscopy and immunohistochemistry, respectively.
RESULTS: The disruption of the lamina densa and matrix construction and the decrease of the immunoreactivity for type IV collagen in subepithelium were observed in association with the accumulation of inflammatory cells in airways 3 days after OVA inhalation. This disorganization of the matrix components in the subepithelium, as well the cellular accumulation, was abolished by the administration of TIMP-2 and dexamethasone. The immunoreactivity for type IV collagen in the subepithelium in OVA-inhaled mice returned to the level of that in saline-inhaled mice 10 days after inhalation in association with a decrease of the cell numbers in the BAL fluid. The immunoreactivity for type III collagen was changed neither 3 nor 10 days after OVA inhalation.
CONCLUSION: These results suggest that epithelial basement membrane gets injured by, at least in part, MMPs as a consequence of cell transmigration through the membrane during acute allergic airway inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372136     DOI: 10.1046/j.1365-2745.2002.01491.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

1.  Cultured lung fibroblasts from ovalbumin-challenged "asthmatic" mice differ functionally from normal.

Authors:  Hisatoshi Sugiura; Xiangde Liu; Fenghai Duan; Shin Kawasaki; Shinsaku Togo; Koichiro Kamio; Xing Qi Wang; Lijun Mao; Youngsoo Ahn; Ronald F Ertl; Tom W Bargar; Abdo Berro; Thomas B Casale; Stephen I Rennard
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

2.  Reconstruction is not renovation - the role of remodeling in asthma.

Authors:  Markus Weckmann; Thomas Trian; Brian Gg Oliver
Journal:  J Asthma Allergy       Date:  2009-03-16

3.  Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling.

Authors:  Alistair K Reinhardt; Stephen E Bottoms; Geoffrey J Laurent; Robin J McAnulty
Journal:  Respir Res       Date:  2005-04-08

4.  Interstitial collagen turnover during airway remodeling in acute and chronic experimental asthma.

Authors:  Georgina González-Avila; Blanca Bazan-Perkins; Cuauhtémoc Sandoval; Bettina Sommer; Sebastian Vadillo-Gonzalez; Carlos Ramos; Arnoldo Aquino-Galvez
Journal:  Exp Ther Med       Date:  2016-07-05       Impact factor: 2.447

Review 5.  What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease?

Authors:  Rosa C Gualano; Ross Vlahos; Gary P Anderson
Journal:  Pulm Pharmacol Ther       Date:  2005-04-25       Impact factor: 3.410

6.  Metalloproteinases and their inhibitors are influenced by inhalative glucocorticoid therapy in combination with environmental dust reduction in equine recurrent airway obstruction.

Authors:  Ann Kristin Barton; Tarek Shety; Angelika Bondzio; Ralf Einspanier; Heidrun Gehlen
Journal:  BMC Vet Res       Date:  2016-12-09       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.